Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer.
Maenhout M, van Vulpen M, Moerland M, Peters M, Meijer R, van den Bosch M, Nguyen P, Frank S, van der Voort van Zyp J.
Maenhout M, et al.
J Contemp Brachytherapy. 2017 Apr;9(2):161-166. doi: 10.5114/jcb.2017.67015. Epub 2017 Apr 3.
J Contemp Brachytherapy. 2017.
PMID: 28533806
Free PMC article.